| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systemic infection A Synowiec, A Szczepański, E Barreto-Duran, LK Lie, K Pyrc Clinical microbiology reviews 34 (2), 10.1128/cmr. 00133-20, 2021 | 216 | 2021 |
| Entry of human coronavirus NL63 into the cell A Milewska, P Nowak, K Owczarek, A Szczepanski, M Zarebski, A Hoang, ... Journal of virology 92 (3), 10.1128/jvi. 01933-17, 2018 | 186 | 2018 |
| Early events during human coronavirus OC43 entry to the cell K Owczarek, A Szczepanski, A Milewska, Z Baster, Z Rajfur, M Sarna, ... Scientific reports 8 (1), 7124, 2018 | 110 | 2018 |
| HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV A Milewska, Y Chi, A Szczepanski, E Barreto-Duran, A Dabrowska, ... Journal of Virology 95 (4), 10.1128/jvi. 01622-20, 2021 | 99 | 2021 |
| Canine respiratory coronavirus, bovine coronavirus, and human coronavirus OC43: receptors and attachment factors A Szczepanski, K Owczarek, M Bzowska, K Gula, I Drebot, M Ochman, ... Viruses 11 (4), 328, 2019 | 92 | 2019 |
| Membrane protein of human coronavirus NL63 is responsible for interaction with the adhesion receptor A Naskalska, A Dabrowska, A Szczepanski, A Milewska, KP Jasik, K Pyrc Journal of virology 93 (19), 10.1128/jvi. 00355-19, 2019 | 87 | 2019 |
| Replication of severe acute respiratory syndrome coronavirus 2 in human respiratory epithelium A Milewska, A Kula-Pacurar, J Wadas, A Suder, A Szczepanski, ... Journal of virology 94 (15), 10.1128/jvi. 00957-20, 2020 | 65 | 2020 |
| Novel coronavirus-like particles targeting cells lining the respiratory tract A Naskalska, A Dabrowska, P Nowak, A Szczepanski, K Jasik, ... PloS one 13 (9), e0203489, 2018 | 45 | 2018 |
| Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses V Napolitano, A Dabrowska, K Schorpp, A Mourão, E Barreto-Duran, ... Cell Chemical Biology 29 (5), 774-784. e8, 2022 | 37 | 2022 |
| Canine respiratory coronavirus employs caveolin-1-mediated pathway for internalization to HRT-18G cells A Szczepanski, K Owczarek, A Milewska, Z Baster, Z Rajfur, JA Mitchell, ... Veterinary research 49, 1-14, 2018 | 37 | 2018 |
| Efficacy of antiviral drugs against the omicron variant of SARS-CoV-2 A Dabrowska, A Szczepanski, P Botwina, N Mazur-Panasiuk, H Jiřincová, ... bioRxiv, 2021.12. 21.473268, 2021 | 12 | 2021 |
| Functional severe acute respiratory syndrome coronavirus 2 virus-like particles from insect cells A Naskalska, A Dabrowska, A Szczepanski, KP Jasik, B Gromadzka, ... Frontiers in Microbiology 12, 732998, 2021 | 12 | 2021 |
| Identification of cellular factors required for SARS-CoV-2 replication A Synowiec, M Jedrysik, W Branicki, A Klajmon, J Lei, K Owczarek, C Suo, ... Cells 10 (11), 3159, 2021 | 11 | 2021 |
| SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis M Lenart, M Górecka, M Bochenek, E Barreto-Duran, A Szczepański, ... Frontiers in Immunology 14, 1123155, 2023 | 10 | 2023 |
| The interplay between the airway epithelium and tissue macrophages during the SARS-CoV-2 infection E Barreto-Duran, A Szczepański, A Gałuszka-Bulaga, M Surmiak, ... Frontiers in Immunology 13, 991991, 2022 | 8 | 2022 |
| In Vitro Inhibition of Zika Virus Replication with Poly (Sodium 4-Styrenesulfonate) P Botwina, M Obłoza, A Szczepański, K Szczubiałka, M Nowakowska, ... Viruses 12 (9), 926, 2020 | 7 | 2020 |
| Visualization of SARS-CoV-2 using immuno RNA-fluorescence in situ hybridization A Kula-Pacurar, J Wadas, A Suder, A Szczepanski, A Milewska, ... JoVE (Journal of Visualized Experiments), e62067, 2020 | 6 | 2020 |
| Pseudanabaena galeata CCNP1313—Biological Activity and Peptides Production M Cegłowska, K Szubert, B Grygier, M Lenart, J Plewka, A Milewska, K Lis, ... Toxins 14 (5), 330, 2022 | 3 | 2022 |
| Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411 R Konkel, A Milewska, NDT Do, EB Duran, A Szczepanski, J Plewka, ... Antiviral Research 219, 105731, 2023 | 2 | 2023 |
| Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response Ł Suprewicz, A Szczepański, M Lenart, E Piktel, K Fiedoruk, ... Antiviral Research 217, 105676, 2023 | 2 | 2023 |
